跳到正文
收录说明
收录范围
保留计量方法研究、相关统计基础,以及实质涉及计量方法的应用、教程、比较和综述。书评、刊务及明确无关内容不公开;身份或相关性证据不足的记录保留待核,补充可靠材料后可重新判断。
预印本来自 arXiv 计量经济学及相关统计、金融分类和主题检索。主题检索从 2021 年起回补;关注作者追溯更早年份,部分历史文献按已核验编号补录。收录不表示通过同行评审,仍可能遗漏。
本库首次提交范围:2004-06-23 — 2026-10-14。
阅读范围
默认显示本库全部预印本。可选“优先阅读”:至少一位作者同时满足有可核验的本站覆盖期刊正式发表记录,且 OpenAlex 总引用超过 1,000 次。按同一作者身份匹配,两项缺一不可。此筛选提供阅读线索,不作为论文质量判断。
日期与排序
默认按最近修订排序;年份和日期筛选使用首次提交时间。同一 arXiv 编号的修订会合并。仅有月份或年份时,日期区间相交也会纳入。

日期精度:到日 6 篇 · 到月 0 篇 · 到年 0 篇

分类与引用
领域和方法依据题名、摘要初步分类,可人工修正;分类不代表论文质量。引用数采用 OpenAlex 单条关联记录,不合计版本。
更新与 AI 解读
正常题录、可靠摘要与引用同步继续;日、周、月简报按核实的发表与修订日期汇总,历史补录保留在文献库。AI 解读依据可靠摘要或已核实原文片段,已有解读保留供阅读参考;缺少可靠材料的条目保持待解读,浏览页面不会触发生成。
6 篇论文
导出

Cluster randomized crossover trials with very few clusters but multiple periods: which analyses for continuous outcomes should be used?

极少集群、多时期的集群随机交叉试验:连续结局应采用哪些分析方法?

Cluster randomized crossover (CRXO) trials are often used when individual randomization is impractical and the number of available clusters is limited. However, statistical analysis of CRXO trials is complex because of the need to account for complex correlation structures over time. It becomes especially challenging when very few clusters are used because standard modeling assumptions may lead to unstable variance estimates, poor confidence interval coverage, and inflated…

AI 解读阅读原文 ↗BibTeX ↓

A tutorial on conducting sample size and power calculations for detecting treatment effect heterogeneity in cluster randomized trials with linear mixed models

用线性混合模型检测整群随机试验处理效应异质性:样本量与功效教程

Cluster-randomized trials (CRTs) are a well-established class of designs for evaluating community-based interventions. An essential task in planning these trials is determining the number of clusters and cluster sizes needed to achieve sufficient statistical power for detecting a clinically relevant effect size. While methods for evaluating the average treatment effect (ATE) for the entire study population are well-established, sample size methods for testing heterogeneity…

AI 解读阅读原文 ↗BibTeX ↓

Which Small-Sample Correction Should Be Used When Analyzing Stepped-Wedge Designs with Time-Varying Treatment Effects?

时变处理效应阶梯楔形设计应采用哪种小样本修正?

Stepped-wedge cluster randomized trials (SW-CRTs) evaluate interventions rolled out across clusters over time. Standard analyses typically use immediate-treatment (IT) models, which assume effects begin at crossover and remain constant thereafter. When effects vary with exposure duration, IT models may misrepresent target effects. Exposure-time indicator (ETI) models address this by allowing treatment effects to differ by time since exposure and by targeting the…

AI 解读阅读原文 ↗BibTeX ↓

On Anticipation Effect in Stepped Wedge Cluster Randomized Trials

阶梯楔形整群随机试验中的预期效应

In stepped wedge cluster randomized trials (SW-CRTs), the intervention is rolled out to clusters over multiple periods. A standard approach for analyzing SW-CRTs utilizes the linear mixed model, where the treatment effect is only present after the treatment adoption, under the assumption of no anticipation. This assumption, however, may not always hold in practice because stakeholders, providers, or individuals who are aware of the treatment adoption timing (especially when…

AI 解读阅读原文 ↗BibTeX ↓

Power analyses for stepped wedge designs with multivariate continuous outcomes

多元连续结局阶梯楔形设计的功效分析

Multivariate outcomes are common in pragmatic cluster randomized trials. While sample size calculation procedures for multivariate outcomes exist under parallel assignment, none have been developed for a stepped wedge design. In this article, we present computationally efficient power and sample size procedures for stepped wedge cluster randomized trials (SW-CRTs) with multivariate outcomes that differentiate the within-period and between-period intracluster correlation…

AI 解读阅读原文 ↗BibTeX ↓

Power analysis for cluster randomized trials with continuous co-primary endpoints

具有连续共同主要终点的集群随机试验功效分析

Pragmatic trials evaluating health care interventions often adopt cluster randomization due to scientific or logistical considerations. Previous reviews have shown that co-primary endpoints are common in pragmatic trials but infrequently recognized in sample size or power calculations. While methods for power analysis based on $K$ ($K\geq 2$) binary co-primary endpoints are available for CRTs, to our knowledge, methods for continuous co-primary endpoints are not yet…

AI 解读阅读原文 ↗BibTeX ↓